Key result
PTPN11-mutated Noonan syndrome presents with severe asymptomatic coronary ectasia that remains stable at 1 year.
Why the study?
While pulmonary valve stenosis and hypertrophic cardiomyopathy are common cardiac manifestations of Noonan syndrome, coronary artery anomalies are rare, potentially life-threatening complications that lack standardized monitoring or treatment protocols.
Case Report (n=1)
No
This case report highlights asymptomatic diffuse coronary artery ectasia and myocardial bridging as rare cardiovascular manifestations in a pediatric patient with PTPN11-related Noonan syndrome, underscoring the need for ongoing echocardiographic and advanced imaging surveillance.
Answers are grounded in this paper and cite their sources.
May warrant coronary imaging consideration in Noonan syndrome; leaves open prevalence and screening utility in larger cohorts.
Background. Noonan syndrome (NS) is a multisystemic genetic disorder primarily affecting the cardiovascular system. While pulmonary valve stenosis and hypertrophic cardiomyopathy are common cardiac manifestations, coronary artery anomalies (CAAs) are rare but potentially life-threatening complications. Case Presentation. A 12-year-old boy with genetically confirmed Noonan syndrome due to a PTPN11 mutation (p.Asn308Asp, c.922A>G) had been followed since infancy. He initially had mild pulmonary valve stenosis that regressed spontaneously. He received intermittent growth hormone therapy, which was discontinued for two years and restarted 1.5 years prior to presentation. Routine echocardiography revealed newly detected coronary artery ectasia involving the left main coronary artery (LMCA) and the left anterior descending (LAD) artery. Coronary computed tomography angiography confirmed ectatic dilation of the LMCA and LAD, with an intramyocardial course of the mid-LAD. Further evaluation with cardiopulmonary exercise testing, myocardial perfusion scintigraphy, and selective coronary angiography demonstrated normal myocardial perfusion, an absence of ischemia, and diffuse coronary ectasia without discrete aneurysm formation. The patient remained asymptomatic, and no flow-limiting lesions were identified. Conclusion. This case highlights a rare vascular manifestation of NS and underscores the importance of vigilant cardiovascular surveillance. Due to the rarity of such cases and the lack of standardized monitoring or treatment protocols, individualized risk stratification remains essential. Reporting such cases is critical for raising awareness and guiding future management strategies for coronary anomalies in Noonan syndrome.
No takes yet. Share an insight, caveat, or question.
Biçer et al. (2026) conducted a case report in Noonan syndrome with coronary artery ectasia (n=1). PTPN11 mutation (p.Asn308Asp, c.922A>G) in Noonan syndrome was evaluated on Coronary artery ectasia dimensions and clinical progression. Noonan syndrome with a PTPN11 mutation presented with asymptomatic coronary ectasia of the LMCA (5.7 mm, z-score +6.16) and LAD (4.5 mm, z-score +5.39) without progression at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: